A comparison of pathomolecular markers of fibrosis and morphology in kidney from autopsies of African Americans and whites

Virchows Archiv

Volumn 450, Issue 1, 2007, Pages 41-50

  Pat, Betty ^a   Hughson, Michael D ^b   Nicol, Jennifer L ^a   Hoy, Wendy E ^a   Gobe, Glenda C ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Chronic renal failure; Fibrosis; Growth factor; Macrophage; Molecular markers; Myofibroblast

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD68 ANTIGEN; CHLORDANE; COLLAGEN; MOLECULAR MARKER; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AFRICAN AMERICAN; APOPTOSIS; ARTICLE; AUTOPSY; BIRTH WEIGHT; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DEATH; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EUROPEAN AMERICAN; FEMALE; FORENSIC MEDICINE; GLOMERULOSCLEROSIS; GLOMERULUS; GROUPS BY AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; KIDNEY CORTEX; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY STRUCTURE; KIDNEY TUBULE; MACROPHAGE; MALE; MYOFIBROBLAST; NEPHROSCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; RACE DIFFERENCE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TISSUE SECTION;

ACTINS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; AUTOPSY; BIOLOGICAL MARKERS; FEMALE; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KIDNEY; MALE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33847618797     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-006-0335-x     Document Type: Article

References (37)

1. Abdi R, Slakey D, Kittur D, Burdick J, Racusen L (1998) Baseline glomerular size as a predictor of function in human renal transplantation. Transplantation 15:329-333
2. Abdi R, Slakey D, Kittur D, Racusen LC (1998) Heterogeneity of glomerular size in normal donor kidneys: impact of race. Am J Kidney Dis 32:43-46
3. August P, Suthanthiran M (2003) Transforming growth factor beta and progression of renal disease. Kidney Int Suppl 87:S99-S104
4. Barker DJP, Gluckman PD, Godfrey KM et al (1993) Fetal nutrition and cardiovascular disease in adult life. Lancet 341:938-941
5. Brenner BM, Garcia DL, Anderson S (1988) Glomeruli and blood pressure: less of one, more the other? Am J Hypertens 1:333-347
6. Chatziantoniou C, Dussaule JC (2005) Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? Am J Physiol Renal Physiol 289:F227-F234
7. Delahunt B, Stehbens WE, Gilbert-Barness E, Shozawa T, Ruger BM (2000) Progeria kidney has abnormal mesangial collagen distribution. Pediatr Nephrol 15:279-285
8. Eddy A (2000) Molecular basis of renal interstitial fibrosis. Pediatr Nephrol 15:290-301
9. El Nahas A, Muchaneta-Kubara E, Essawy M, Soylemezoglu O (1997) Renal fibrosis: insights into pathogenesis and treatment. Int J Biochem Cell Biol 29:55-62
10. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P (2004) The burden of adult hypertension in the United States 1999-2000. Hypertension 44:398-404
11. Gabbiani G (1996) The cellular derivation and life span of the myofibroblast. Pathol Res Pract 192:708-711
12. Go AS, Chertow GM, Fan D et al (2004) Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296-1305
13. Gobe G, Axelsen R (1991) The role of apoptosis in the development of renal cortical tubular atrophy associated with healed experimental renal papillary necrosis. Pathology 23:213-223
14. Goumenos D, Brown C, Shortland J, El Nahas A (1994) Myofibroblasts, predictors of progression of mesangial IgA nephropathy Nephrol Dial Transplant 9:1418-1425
15. Goumenos D, Tsamandas A, Oldroyd S, Sotsiou F, Tsakas S, Petropoulou C, Bonikos D, El Nahas A, Vlachojannis J (2001) Transforming growth factor-β1 and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease. Nephron 87:240-248
16. Hoy WE, Hughson MD, Smith SM, Megill DM (1993) Mesangial proliferative glomerulonephritis in southwestern American Indians. Am J Kidney Dis 21:486-496
17. Hughson MD, Johnson K, Young RJ, Hoy WE, Bertram JF (2002) Glomerular size and glomerulosclerosis: relationships to disease categories, glomerular solidification, and ischemic obsolescence. Am J Kidney Dis 39:679-688
18. Hughson M, Farris AB 3rd, Douglas-Denton R, Hoy WE, Bertram JF (2003) Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int 63:2113-2122
19. Hughson MD, Douglass-Denton R, Bertram JF, Hoy WE (2006) Hypertension, glomerular number, and birth weight in African American and white subjects in the Southeastern United States. Kidney Int 69:671-678
20. Keller G, Zimmer G, Mall G et al (2003) Nephron number in patients with primary hypertension. N Engl J Med 348:101-108
21. Kerr JFR, Gobe G, Winterford C, Harmon BV (1995) Anatomical methods in cell death. In: Schwartz LM, Osborne BA (eds) Methods in cell biology. Academic, San Diego, CA, pp 1-27
22. Labarrere CA, Zolaga GP (2004) C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis. Am J Med 117:499-507
23. Lan H, Mitsuhashi H, Ng Y, Nikolic-Paterson D, Yang N, Mu W, Atkins R (1997) Macrophage apoptosis in rat crescentic glomerulonephritis. Am J Pathol 151:531-538
24. Lane A, Johnson DW, Pat B, Winterford C, Endre Z, Wei M, Gobe GC (2002) Interacting roles of myofibroblasts, apoptosis and fibrogenic growth factors in the pathogenesis of renal tubulointerstitial fibrosis. Growth Factors 20:109-119
25. Law CM, deSwiet M, Osmond C et al (1993) Initiation of hypertension in utero and its amplification throughout life. BMJ 306:24-27
26. Lopes AA, Port FK (1995) The low birth weight hypothesis as a plausible explanation for the back/white differences in hypertension, non-insulin dependent diabetes, and end-stage renal disease. Am J Kidney Disease 25:350-356
27. McClellan WM, Langston RD, Presley (2004) Medicare patients with cardiovascular disease have a high frequency of chronic kidney disease and a high rate of progression to end-stage renal disease. J Am Soc Nephrol 15:1912-1919
28. Ng Y-Y, Huang T-P, Yang W-C, Chen Z-P, Yang A-H, Mu W, Nicolic-Paterson D, Atkins R, Lan H (1998) Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 54:864-876
29. Morita H, Hasegawa T, Minamoto T, Oda Y, Inui K, Tayama H, Nakao N, Nakamoto Y, Ideura T, Yoshimura A (2003) Collagenofibrotic glomerulopathy with a widespread expression of type-V collagen. Virchows Arch 442:163-168
30. Ong A, Fine L (1993) Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: implications for human renal disease progression. Am J Kidney Dis 23:205-209
31. Pesce CM, Schmidt K, Fogo A et al (1994) Glomerular size and the incidence of renal disease in African Americans and Caucasians. J Nephrol 7:355-358
32. Peters H, Border WA, Noble NA (1998) Targeting TGF-β overexpression in renal disease: maximising the anti-fibrotic action of angiotensin II blockade. Kidney Int 54:1570-1580
33. Rodriguez-Iturbe B, Pons H, Quiroz Y, Gordon K, Rincon J, Chaves M, Parra G, Herrera-Acosta J, Gomez-Garre D, Largo R, Egido J, Johnson RJ (2001) Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 59:2222-2232
34. Schmidt K, Pesce C, Liu QL et al (1992) Large glomerular size in Pima Indians: lack of change with diabetic nephropathy. J Am Soc Nephrol 3:229-235
35. Thomas SE, Anderson S, Gordon KL, Oyama TT, Shankland SJ, Johnson RJ (1998) Tubulointerstitial damage in ageing: evidence for underlying peritubular capillary damage, a potential role for ischemia. J Am Soc Nephrol 9:231-242
36. Young B, Burdmann E, Johnson R, Alpers C, Giachelli C, Eng E, Andoh T, Bennett W, Couser W (1995) Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int 48:439-448
37. Young RJ, Hoy WE, Kincaid-Smith P, Seymour AE, Bertram JF (2000) Glomerular size and glomerulosclerosis in Australian aborigines. Am J Kidney Dis 36:481-489